Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eisai Wins Japan Court’s Support for Aricept Patent Extension
Bloomberg
Wednesday, February 23, 2011 - 7:48am
tags:
Eisai, Aricept, Japan
Regeneron: A Well-Executed Strategy
Seeking Alpha
Tuesday, February 22, 2011 - 6:27pm
tags:
Regeneron
Analysts say new RFP makes SIGA likely winner of gov't smallpox-drug contract; shares leap
Yahoo/AP
Tuesday, February 22, 2011 - 5:59pm
tags:
analysts, government contracts, SIGA technologies
Clinical Data: A Pretty Good Deal for Forest Labs
Seeking Alpha
Tuesday, February 22, 2011 - 5:58pm
tags:
Forest Labs, M&A, Clinical Data
Bone Drugs by Merck, Roche, Novartis May Add Leg Fractures
Bloomberg
Tuesday, February 22, 2011 - 5:56pm
tags:
Merck, Roche, Novartis, osteoporosis, bisphosphonates, Boniva, Reclast, Fosamax
Dendreon: The Big Push on Provenge Begins
Seeking Alpha
Tuesday, February 22, 2011 - 12:54pm
tags:
Provenge, Dendreon, vaccines, prostate cancer
FDA chief vows fast delivery of new biosimilar rules
Fierce Biotech
Tuesday, February 22, 2011 - 11:18am
tags:
FDA, biosimilars, Peggy Hamburg
Suits Against Vaccine Makers Curbed by U.S. Supreme Court
Bloomberg
Tuesday, February 22, 2011 - 11:17am
tags:
vaccines, Supreme Court, lawsuits, Pfizer, Wyeth
Bayer chief looks to pump up pharma unit
Fierce Pharma
Tuesday, February 22, 2011 - 10:50am
tags:
Bayer, Marijn Dekkers, Pharma CEOs
Just How Likely Is It That Diabetes Drugmaker Amylin Could Go Bankrupt?
BNET Pharma
Tuesday, February 22, 2011 - 10:48am
tags:
diabetes, Amylin, Byetta
Takeda yanks established drug on efficacy questions
Fierce Pharma
Tuesday, February 22, 2011 - 10:47am
tags:
Takeda, Dasen
Which Sales Reps Rank Highest With Oncologists?
Pharmalot
Tuesday, February 22, 2011 - 10:36am
tags:
drug reps, oncologists, Roche, Genentech, Novartis
Gilead to acquire Calistoga Pharmaceuticals for $375M
Bizjournals.com
Tuesday, February 22, 2011 - 10:25am
tags:
Gilead Sciences, Calistoga Pharmaceuticals, M&A
Dynavax says universal flu vaccine working well in tests
Bizjournals.com
Tuesday, February 22, 2011 - 10:22am
tags:
Dynavax, Flu, vaccines
Human Genome: Betting on Benlysta Approval
Seeking Alpha
Tuesday, February 22, 2011 - 9:40am
tags:
Benlysta, FDA, Human Genome Sciences, lupus
Exelixis seen narrowing Q4 loss, increasing revenue
Bizjournals.com
Tuesday, February 22, 2011 - 9:28am
tags:
earnings, Exelixis
Forest Laboratories to Buy Clinical Data for $1.2 Billion
Bloomberg
Tuesday, February 22, 2011 - 9:24am
tags:
M&A, Forest Labs, Clinical Data
Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
Yahoo
Tuesday, February 22, 2011 - 9:23am
tags:
JNJ, Crucell, M&A
Ranbaxy Got 30% Market Share for Generic Aricept in December
Bloomberg
Tuesday, February 22, 2011 - 9:18am
tags:
Ranbaxy, generics, Aricept, Eisai, Alzheimer's disease
Kansas recovers $5.8M in Medicaid fraud settlements
Bizjournals.com
Tuesday, February 22, 2011 - 9:16am
tags:
Kansas, Medicaid, settlements, fraud

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.